With inflation readings softening in several regions and central banks weighing their next moves, cash flow quality is back in focus for value investors. When growth expectations swing with every data release, companies that appear undervalued on discounted cash flow analysis stand out as potential anchors for a long term portfolio. The Undervalued Stocks Based On Cash Flows screener targets exactly that, highlighting stocks where current prices sit below SWS DCF fair value. In this article, you will see 3 of the stocks flagged by this tool and how their cash flow profiles may appeal to patient, valuation conscious investors.
AstraZeneca (LSE:AZN)
Overview: AstraZeneca is a large biopharmaceutical company that discovers, develops, manufactures, and sells prescription medicines across oncology, cardiovascular and metabolic diseases, respiratory and immunology, vaccines, and rare diseases to healthcare providers worldwide.
Operations: AstraZeneca generates about US$60.4b in revenue from its Pharmaceuticals segment.
Market Cap: £195.3b
Investors looking at AstraZeneca are getting exposure to a big pharma business with a broad, late stage pipeline in areas like oncology and rare diseases, backed by high quality earnings and a Return on Equity above 20%. Recent approvals and licenses for drugs such as Datroway, Enhertu and Zegfrovy point to new cash flow streams. At the same time, earnings growth, rising margins and a wide gap to Simply Wall St’s DCF estimate suggest the stock may be pricing in a lot of regulatory and patent risk. Combined with elevated debt, insider selling and pressure from price controls, AstraZeneca is a complex situation that may warrant a closer look beyond the headlines.
High quality earnings, a broad late stage pipeline and a wide gap to Simply Wall St’s DCF estimate suggest AstraZeneca’s story is more complex than the headline risks. As a result, it may be worth reviewing the DCF valuation analysis for AstraZeneca
Foresight Group Holdings (LSE:FSG)
Overview: Foresight Group Holdings is an alternative asset manager that runs infrastructure, private equity, venture capital and listed funds, with a focus on renewable energy, social and digital infrastructure, and smaller company investments for institutional and retail clients across the UK, Europe and Australia.
Operations: Foresight Group Holdings generates about £114.8m from Real Assets and £50.1m from Private Equity, with most revenue coming from the United Kingdom at £126.4m and Australia at £25.7m.
Market Cap: £528.0m
Foresight Group Holdings stands out because it pairs high quality, fee based revenue with profitability metrics such as a 27.7% net margin and a 47.8% Return on Equity, in a business tied to long term themes including energy transition and infrastructure. At the same time, the stock trades on a lower P/E than many peers and sits below some analyst fair value estimates, while ongoing share buybacks are reducing the share count and supporting earnings per share. On the other hand, there is meaningful exposure to UK and European policy risk, pressure on fees, and reliance on performance fees that can move with markets. This makes it especially important to understand how sustainable the growth and margin profile is before placing significant weight on current analyst views.
Foresight Group Holdings combines fee based cash flows with a lower P/E and active buybacks, yet the full picture is not reflected in the headline metrics. Get the story behind the analysis report for Foresight Group Holdings
BAE Systems (LSE:BA.)
Overview: BAE Systems is a large defense and aerospace company that supplies combat aircraft, warships, armored vehicles, munitions, electronic warfare systems, and cyber security services to governments and defense customers across the US, UK, Europe, the Middle East, Australia, and other regions.
Operations: BAE Systems generates most of its revenue from Electronic Systems at £7.5b, Air at £7.4b, Maritime at £6.6b, and Platforms & Services at £5.0b, with smaller contributions from Cyber & Intelligence at £2.4b and HQ activities.
Market Cap: £53.3b
BAE Systems provides investors with exposure to global defense budgets and reports a £75b order backlog that offers visibility on contracted work as governments upgrade aircraft, missiles, and electronic warfare capabilities. The company operates at a scale that allows participation in major programs such as Eurofighter, missile systems, and advanced electronic warfare contracts in markets including Korea and Brazil. Key risks include reliance on a relatively small number of large government customers, environmental, social, and governance (ESG) concerns that can affect sentiment toward defense stocks, and potential supply chain or capacity constraints that may affect the pace at which backlog is converted into revenue. These factors together suggest that BAE Systems may warrant deeper research beyond headline metrics.
BAE Systems’ £75b backlog may be masking a bigger story about future earnings power and contract risk. See how current orders, programs and cash flows fit together in the analysis report for BAE Systems
The 3 stocks in this article are just a starting point. The full Undervalued Stocks Based On Cash Flows tool surfaces 37 more companies where discounted cash flow signals and business quality create equally compelling narratives through the Undervalued Stocks Based On Cash Flows screener. Use Simply Wall St to identify and analyze the specific cash flow catalysts, balance sheet profiles, and valuation gaps that matter most so you can focus on the highest conviction ideas for your watchlist.
Take Control of Your Investment Journey
If AstraZeneca or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Seeking Fresh Alternatives Before Others?
Fresh opportunities can move from under the radar to flying high quickly, and once momentum is caught, ideal entry points start dropping away. Consider acting before the crowd.
- Spot companies where cash flows already support strong balance sheets, and let the list of solid balance sheet and fundamentals (20 results) guide you toward ideas others might overlook while it still matters.
- Explore long-term income potential by scanning for high yield stocks in the 5 dividend fortresses that aim to combine durable payouts with staying power when markets shift.
- Consider future-facing opportunities early by checking the 54 AI infrastructure stocks for companies supplying the picks and shovels behind AI data centers, networking, and power capacity while they are still under the radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com